Mechanisms of Action of GLP-1 Agonists in T2D

April 29, 2019 12:36 pm

Expert colleagues react to the benefits demonstrated through data with the use of GLP-1 agonists for the treatment of type 2 diabetes and explore how the various options work.

Category: News
About The Author
-
Previous

GLP-1 Agonist Therapy in a Patient With T2D and CVD
Next

Type 2 Diabetes and Cardiovascular Disease: Risk Factors

Related Videos

Type-2-Diabetes-Dr-Stephen-Hull-Practical-Advice-for-People-with-T2D-and-Heart-Disease

Type 2 Diabetes: Dr Stephen Hull – Practical Advice for People with T2D and Heart Disease

Diabetes-debunked-Fact-vs.-fiction-on-ways-to-prevent-manage-and-reverse-the-disease

Diabetes debunked: Fact vs. fiction on ways to prevent, manage, and reverse the disease

Diabetes-Epigenome-Atlas-DGA-and-T2D-Knowledge-Portal-September-26-2019-Webinar

Diabetes Epigenome Atlas (DGA) and T2D Knowledge Portal: September 26, 2019 Webinar

Team-based-care-for-patients-with-T2D-and-kidney-disease-Katherine-R-Tuttle-Jay-H-Shubrook

Team-based care for patients with T2D and kidney disease | Katherine R Tuttle & Jay H Shubrook

Dont-manage-type-2-diabetes-reverse-it

Don’t manage type 2 diabetes, reverse it!

PILA-PHARMA

PILA PHARMA